The Victoria’s Secret Contract That Anticipated a Pandemic
It’s no wonder the buyout firm Sycamore Partners is trying to back out of its
anticipated
Gilead stock falls after disappointing early trial results for highly anticipated coronavirus treatment
Stock trading was briefly halted Thursday for California-based Gilead Sciences, after a draft report said